NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Important screening stories this week – breast, colon, prostate cancers

Posted By

Tags

Journalist Christie Aschwanden’s mammography story in the Los Angeles Times is an example of clear, explanatory journalism.

Two pieces by Reuters Health were noteworthy – yet drew surprisingly little news coverage:

• One was on an American College of Obstetricians and Gynecologists report reminding women that they have several options for colon cancer screening. Too many stories – here’s an example – focus only on colonoscopy or only on virtual colononscopy.

• Another was on a prostate cancer study that showed, in the words of the lead researcher, “the older you get, the likelihood of benefiting from intervention becomes increasingly slim.” The screening angle was explained in the story: “The advent of prostate cancer screening with PSA (prostate-specific antigen) testing has meant that a large number of men are now diagnosed with early-stage cancer that’s unlikely to ever become life-threatening.”

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.